Catheter News and Research

RSS

In medicine, a catheter is a tube that can be inserted into a body cavity, duct, or vessel. Catheters . In most uses, a catheter is a thin, flexible tube ("soft" catheter), though in some uses, it is a larger, solid ("hard") catheter. A catheter left inside the body, either temporarily or permanently, may be referred to as an indwelling catheter. A permanently inserted catheter may be referred to as a permcath.

Bone marrow stem cells do not improve cardiac function in heart attack patients

There has been increasing evidence that stem cells contribute to regeneration of cardiac tissue and the development of new blood vessels following a heart attack, thus opening up new prospects for stem-cell based therapies.

1 Mar 2006

Coronary stents that release the drugs sirolimus or paclitaxel produce similar results

Use of coronary stents that release the drugs sirolimus or paclitaxel produced similar results in patients with new coronary artery lesions, according to a study in JAMA: The Journal of the American Medical Association.

24 Feb 2006

Double whammy of drugs plus ultrasound unblocks arteries

According to a pilot study led by the University of Cincinnati, standard clot-busting medication when used in combination with low-energy ultrasound appears to re-open clogged arteries in stroke patients better than medication alone.

20 Feb 2006

Lower doses of clot-busting drug safer for stroke patients

A Johns Hopkins study has shown that patients treated for a type of stroke caused by bleeding in the brain, or intracerebral hemorrhage, survived more often if given 1 milligram instead of the previously studied 3 milligram dose of the clot-busting drug tissue plasminogen activator (tPA).

19 Feb 2006

Topical anaesthesia and morphine effective in treating procedural pain in newborn infants

Researchers at The Hospital for Sick Children (SickKids) have found that intravenous morphine used alone or with a topical anaesthetic (tetracaine) effectively reduced levels of pain in newborn infants undergoing insertion of central venous catheters (central lines).

17 Feb 2006

New children's heart valve

New valves and stents made of super-elastic, shape-memory metal alloy combined with less invasive procedure mean quicker recovery for children with heart disease.

16 Feb 2006

New technology could replace time-intensive urine specimens

For the millions of people who suffer from urinary tract infections each year and the doctors who treat them, a promising new biosensor technology has been developed that may replace antiquated testing methods and save precious health care dollars.

12 Feb 2006

Biosense Webster receives FDA approval for technology to treat heart rhythm disease

The U.S. Food and Drug Administration (FDA) today approved an innovative combination of technologies that will enhance a doctors' ability to treat patients with abnormal heart rhythms (cardiac arrhythmias).

7 Feb 2006

Baby Grace goes home after having heart surgery as a fetus

A baby girl, who had the world's first heart "stent" procedure in the womb was discharged from hospital on Friday and went home 17 days after her birth.

31 Jan 2006

Uterine artery embolization shortens hospital stay but increases minor complications

Compared to traditional surgery for uterine fibroids, a new minimally invasive procedure leads to shorter hospitalization and a quicker return to everyday activities, researchers report.

25 Jan 2006

Rush University Medical Center to use new stent specifically designed for use in the brain to reduce the threat of stroke

Rush University Medical Center is the first site in Illinois to use the first stent specifically designed for use in the brain. While it has been possible to attempt to open narrowed brain vessels using existing stents made of stainless steel and intended for use in the heart, the new Wingspan brain stent is designed to be gentler on the more fragile brain vessels.

23 Jan 2006

FDA fast track status for Alfimeprase

Nuvelo Inc. today announced that it has been granted fast track designation by the U.S. Food and Drug Administration (FDA) for its lead product candidate, alfimeprase, for the treatment of acute peripheral arterial occlusion (PAO), or "leg attack."

23 Jan 2006

Results of a five-year study on peripherally inserted catheters

Boston Scientific Corporation today announced the results of a five-year retrospective study on Peripherally Inserted Central Catheters (PICCs) with Pressure Activated Safety Valve (PASV(R)) Technology, indicating a significant reduction in rates of both occlusion (closure) and infection.

18 Jan 2006

Emergency angioplasty better than clot-busting drugs

Across America, hospitals large and small have been racing to offer angioplasty and other minimally invasive treatments to open blocked heart arteries. But not all of them have the ability to do it on an emergency basis, performing angioplasty around the clock on heart attack patients. So, during evenings and weekends, many hospitals use clot-busting drugs instead.

16 Jan 2006

Abdominal chemotherapy boosts survival in ovarian cancer patients

Women with Stage III ovarian cancer given a combination of intravenous and intraperitoneal chemotherapy following surgical debulking of tumor had a median survival nearly 16 months longer than women who received IV chemotherapy alone

10 Jan 2006

Uterine fibroid embolization shows high rate of long-term symptom control

In the first long term study of patients receiving uterine fibroid embolization (UFE) for the relief of symptoms from fibroid tumors 73% report continued relief five years later.

10 Jan 2006

Intraperitoneal chemotherapy prolongs survival for women with advanced ovarian cancer

A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.

8 Jan 2006

New procedure offers hope to patients at high risk for recurrent stroke

Surgeons at NewYork-Presbyterian Hospital/Weill Cornell Medical Center are the first in the New York City metropolitan area to successfully implant into the brain arteries a new stent specifically designed to treat high-risk stroke patients who have not previously responded to medical therapy.

6 Jan 2006

Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients

A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.